William C. Hahn

Molecular Biology · 2000–2021

A researcher in the Science corpus: 35 papers; trusts 3 researchers and is trusted by 17 researchers here, as inferred from the citation graph.

Subfields

Molecular Biology — 381 citations into it; #3,279 of 17,773 by trust here, #520 by citations
Oncology — 165 citations into it; #107 of 1,698 by trust here, #166 by citations
Genetics — 106 citations into it; #5,548 of 6,854 by trust here, #509 by citations
Physiology — 21 citations into it
Aging — 13 citations into it

Whom William C. Hahn trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts William C. Hahn overall

Papers from William C. Hahn's perspective

Ordered by how strongly the researchers William C. Hahn trusts endorse each paper. Same corpus, a different order for every researcher.

Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium (Breast Cancer Research)
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. (Genes & Development)
Prospective identification of tumorigenic breast cancer cells (Proceedings of the National Academy of Sciences of the United States of America)
Stem cells, cancer, and cancer stem cells (Nature)
PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization (Nature Medicine)
Tumor self-seeding by circulating cancer cells (Cell)
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells (Science)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. (Cancer Cell)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells (Nature)
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. (Molecular Cancer Therapeutics)

Their papers

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. (2006) — 1,888 citations
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. (2003) — 1,178 citations
Malignant astrocytic glioma: genetics, biology, and paths to treatment. (2007) — 2,428 citations
Minimizing the risk of reporting false positives in large-scale RNAi screens (2006) — 480 citations
Lentivirus-delivered stable gene silencing by RNAi in primary cells. (2003) — 1,579 citations
BET bromodomain inhibition as a therapeutic strategy to target c-Myc (2011) — 2,801 citations
Initial genome sequencing and analysis of multiple myeloma (2011) — 1,464 citations
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. (2006) — 604 citations
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer (2017) — 1,354 citations
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (2009) — 3,376 citations
KRAS and YAP1 converge to regulate EMT and tumor survival (2014) — 758 citations
Modelling the molecular circuitry of cancer (2002) — 1,006 citations
Defining a Cancer Dependency Map (2017) — 2,742 citations
Computational correction of copy-number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells (2017) — 1,706 citations
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. (2011) — 983 citations
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. (2007) — 645 citations
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity (2008) — 705 citations
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants (2005) — 677 citations
SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas (2009) — 956 citations
COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation (2010) — 731 citations